GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] 4th independent test on JEEP — 97.3% on a claimed 97.0%, and the trend is the interesting part — 44 comments in the full submission. View in context.
1.5k
c/tirzepatide·submitted 4 months ago by u/elin_varga

[Lab] 4th independent test on JEEP — 97.3% on a claimed 97.0%, and the trend is the interesting part

Labbranch of 7 comments

Result first, context after: 4th independent test on JEEP — 97.3% on a claimed 97.0%, and the trend is the interesting part . Everything below is how it was ordered, stored and sent. Pulling the figures out of the title: 97.3% and 97.0%. All of it is written down as it happened rather than reconstructed. Weekly…

Read the full submission and all 44 comments →

This branch

7 comments, started 4 months ago
u/hassan_nilsen102 points·4 months ago

Week 34 was the first time the scale moved after a five-week stall. I changed nothing in that window.

replysharereportpermalink
[deleted]38 points·4 months ago

[deleted]

replysharereportpermalink
u/hassan_nilsen27 points·4 months ago·edited

sulphur burps are the signature complaint and they are not dangerous

replysharereportpermalink
u/sten_bhattacharya8 points·4 months ago

SURMOUNT-1 landed around 21% at 72 weeks on the top arm

replysharereportpermalink
u/throwaway_wl20267 points·4 months ago

sulphur burps are the signature complaint and they are not dangerous

Saving this one. It is the clearest statement of the stall problem I have read here.

replysharereportpermalink
u/aurel_lindqvist2 points·4 months ago

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

replysharereportpermalink
u/kian_ekstrom15 points·4 months ago

pens and vials are the same molecule, the price is the difference

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →